Family History and Triple-Negative Breast Cancer: What to Know

Photo Credit: kate_sept2004 / Getty Images

SOURCES: 

Kimberley Lee, MD, assistant member, department of breast oncology, Moffitt Cancer Center.

Rachel Greenup, MD, associate professor of surgery (oncology, breast), Yale School of medicine; chief, breast surgery, The Breast Center at Smilow Cancer Hospital. 

Anne Marie McCarthy, PhD, assistant professor of epidemiology, Perelman School of Medicine, University of Pennsylvania.

Eric Winer, MD, professor of pharmacology; professor of medicine (medical oncology), Yale School of Medicine; director, Yale Cancer Center; physician-in-chief, Smilow Cancer Network. 

Frontiers in Molecular Biosciences: “Triple-Negative Breast Cancer: A Brief Review About Epidemiology, Risk Factors, Signaling Pathways, Treatment and Role of Artificial Intelligence.”

American Cancer Society: “Breast Cancer Risk Factors You Cannot Change,” “Study: New Genes Linked With Triple-Negative Breast Cancer,” “American Cancer Society Recommendations for the Early Detection of Breast Cancer.” 

Journal of the National Cancer Institute: “Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing.” 

CDC: “Family Health History and the BRCA1 and BRCA2 genes,” “Family Health History Risk Categories,” “BRCA Gene Mutations.” 

Current Breast Cancer Reports: “Disparities in Genetic Testing and Care among Black women with Hereditary Breast Cancer.”

JAMA Surgery: “Evaluation of Triple-Negative Breast Cancer Early Detection via Mammography Screening and Outcomes in African American and White American Patients.